Guido Schwegler

555 total citations
10 papers, 242 citations indexed

About

Guido Schwegler is a scholar working on Oncology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Guido Schwegler has authored 10 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pathology and Forensic Medicine and 4 papers in Rheumatology. Recurrent topics in Guido Schwegler's work include Multiple Sclerosis Research Studies (3 papers), Systemic Lupus Erythematosus Research (2 papers) and Polyomavirus and related diseases (2 papers). Guido Schwegler is often cited by papers focused on Multiple Sclerosis Research Studies (3 papers), Systemic Lupus Erythematosus Research (2 papers) and Polyomavirus and related diseases (2 papers). Guido Schwegler collaborates with scholars based in Switzerland and Italy. Guido Schwegler's co-authors include Josef P. Kapfhammer, ME Schwab, Stephanie Schneider, Silke Potthast, Steffen Böhm, Paul Komminoth, Andreas Böck, Barbara Tettenborn, Özgür Yaldizli and Norman Putzki and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Guido Schwegler

9 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guido Schwegler Switzerland	6	91	86	56	55	44	10	242
Karin Mausner-Fainberg Israel	10	54 0.6×	59 0.7×	56 1.0×	18 0.3×	76 1.7×	18	351
Koichi Miyagi Japan	11	71 0.8×	108 1.3×	24 0.4×	68 1.2×	17 0.4×	16	347
Vana Tsimourtou Greece	12	123 1.4×	262 3.0×	27 0.5×	117 2.1×	31 0.7×	20	475
Jitesh Rana United States	4	82 0.9×	247 2.9×	36 0.6×	82 1.5×	51 1.2×	10	382
Camille L. Pittet Canada	7	77 0.8×	65 0.8×	26 0.5×	21 0.4×	25 0.6×	7	354
Frederik Bartels Germany	11	60 0.7×	69 0.8×	23 0.4×	128 2.3×	6 0.1×	18	249
Michitaro Ichikawa Japan	6	46 0.5×	121 1.4×	14 0.3×	37 0.7×	24 0.5×	18	340
Debbie K. Song United States	11	37 0.4×	55 0.6×	71 1.3×	103 1.9×	9 0.2×	16	345
Katayoun Alikhani Canada	8	21 0.2×	106 1.2×	27 0.5×	74 1.3×	60 1.4×	15	259
Szymon Janczar Poland	10	54 0.6×	19 0.2×	35 0.6×	29 0.5×	13 0.3×	29	338

Countries citing papers authored by Guido Schwegler

Since Specialization

Citations

This map shows the geographic impact of Guido Schwegler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Schwegler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Schwegler more than expected).

Fields of papers citing papers by Guido Schwegler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Schwegler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Schwegler. The network helps show where Guido Schwegler may publish in the future.

Co-authorship network of co-authors of Guido Schwegler

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Schwegler. A scholar is included among the top collaborators of Guido Schwegler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Schwegler. Guido Schwegler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Michel, Patrik, Michael Diepers, Pasquale Mordasini, et al.. (2021). Acute revascularization in ischemic stroke: Updated Swiss guidelines. SHILAP Revista de lepidopterología. 5(1). 2514183X2199922–2514183X2199922. 4 indexed citations

Sacco, Rosaria, Giulio Disanto, Christian P. Kamm, et al.. (2019). Infusion-related reactions during Natalizumab treatment: Do we still need a post-infusion observation period?. Multiple Sclerosis and Related Disorders. 38. 101523–101523. 3 indexed citations

Schneider, Stephanie, Silke Potthast, Paul Komminoth, Guido Schwegler, & Steffen Böhm. (2017). PD-1 Checkpoint Inhibitor Associated Autoimmune Encephalitis. Case Reports in Oncology. 10(2). 473–478. 58 indexed citations

Kamm, Christian P., Marwan El‐Koussy, Oliver Findling, et al.. (2014). Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial. PLoS ONE. 9(1). e86663–e86663. 21 indexed citations

Kamm, Christian P., Marwan El‐Koussy, Oliver Findling, et al.. (2012). Atorvastatin added to interferon beta for relapsing multiple sclerosis: a randomized controlled trial. Journal of Neurology. 259(11). 2401–2413. 28 indexed citations

Putzki, Norman, et al.. (2010). Natalizumab Reduces Clinical and MRI Activity in Multiple Sclerosis Patients with High Disease Activity: Results from a Multicenter Study in Switzerland. European Neurology. 63(2). 101–106. 50 indexed citations

Wiederkehr, Michael R., et al.. (2010). Focal neuromyotonia: do I love you?. Journal of Neurology. 257(10). 1727–1729. 2 indexed citations

Böck, Andreas & Guido Schwegler. (2007). Intracerebral haemorrhage as first manifestation of Pseudoxanthoma elasticum. Clinical Neurology and Neurosurgery. 110(3). 262–264. 19 indexed citations

Böck, Andreas & Guido Schwegler. (2005). Vertebral artery halo sign in giant cell arteritis. Practical Neurology. 5(6). 360–361.

10.

Schwegler, Guido, ME Schwab, & Josef P. Kapfhammer. (1995). Increased collateral sprouting of primary afferents in the myelin-free spinal cord. Journal of Neuroscience. 15(4). 2756–2767. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact